enCore Energy Corp.
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Richard H. Little
- Full Time Employees
- 251
- Sector
- Non-energy minerals
- Industry
- Other metals/Minerals
- Address
- One Galleria Tower Dallas TX United States 75240
- IPO Date
- May 12, 2010
- Website
- encoreuranium.com
- Similar Companies
- Business
- enCore Energy Corp. (TSX:EU, TSXV:EU) is a U.S.-based uranium producer focused on in-situ recovery (ISR) mining and exploration of uranium resources in the United States. The company produces uranium oxide (U3O8) through its operational ISR facilities, including the Rosita and Alta Mesa projects in South Texas; it also holds interests in the South Texas Altamira, Dewey-Burdock in South Dakota, and gas Hills in Wyoming projects. enCore offers uranium sales contracts to utilities, exploration services, and resource development activities targeting low-cost ISR production methods suitable for sandstone-hosted deposits. Founded in 2014 and headquartered in Vancouver, Canada, with key operations centered in Texas and other U.S. states, enCore targets North American nuclear utilities and energy companies seeking domestic uranium supply amid growing clean energy demand. The company operates across the full uranium value chain from exploration and permitting to production and sales, with a portfolio of permitted and near-term projects positioning it as one of the few U.S. uranium producers. Recent developments include the first uranium production at the Alta Mesa project in late 2024, marking a significant milestone in expanding licensed production capacity to over 20 million pounds annually; strategic alliances with utilities for long-term offtake agreements; and ongoing construction at the Rosita Central facility to boost output. In 2025, enCore announced the acquisition of additional mineral rights in South Texas and a funding round to support commissioning of new satellite facilities. These changes reflect the company's shift toward multi-project ISR operations, enhancing its position in the U.S. uranium market.
Company News
Coty Sharpens Climate Goals, Cuts Water and Packaging Use in FY26 Sustainability Report
Live Nation Entertainment Announces Pricing of Private Senior Notes Offering
enCore Energy Completes Distribution of Verdera Common Shares to its Shareholders
Gentoo Media Inc. agrees EUR 50 million senior secured loan and secures full underwriting commitments for a planned EUR 50 million share issue to refinance its December 2026 bonds
Notice to attend an Extraordinary General Meeting of Sivers Semiconductors AB
enCore Energy Corp. (NASDAQ:EU) Stock Has Consensus Price Target of $2.90 According to Analysts
Richard Little Purchases 10,000 Shares of enCore Energy (NASDAQ:EU) Stock
enCore Energy Engages North Star Investor Relations and Provides Update on Distribution of Verdera Common Shares to its Shareholders
Merck Receives Positive EU CHMP Opinion for KEYTRUDA® (pembrolizumab) Plus Padcev® (enfortumab vedotin-ejfv) as Perioperative Treatment for Adults With Resectable Muscle-Invasive Bladder Cancer (MIBC)
ACG METALS LIMITED ACG Delivers Material Uplift in Gediktepe NPV to US$1.2bn ACG Metals Limited
enCore Energy Provides Update on Distribution of Verdera Common Shares to its Shareholders
ExxonMobil: Cash Tender Offers for Outstanding 2030 1.900% Senior Notes and 2031 2.150% Senior Notes
Brightstar Lottery PLC Announces Tender Offer and a Benchmark Offering of Senior Secured Notes Due 2032
Power Metallic Defines High-Grade Maiden Resource at Lion Averaging ~3.9% CuEq, with >85% Indicated and Significant Expansion Potential
ACG to Acquire Keşkek Licence to Extend Gold Production
enCore Energy Corp. Featured in "The Nuclear Option" Documentary Series
ACG Metals Achieves First Copper Concentrate Production at Gediktepe
Universal Music Group N.V. Reports Weekly Transactions under its €250 Million Share Buyback Program
Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid™ Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season
Fosun International Delivers 160.3% YoY Profit Growth in 1H2026